Correlation Between Vivos Therapeutics and Oncology Institute
Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Oncology Institute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Oncology Institute into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vivos Therapeutics and The Oncology Institute, you can compare the effects of market volatilities on Vivos Therapeutics and Oncology Institute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Oncology Institute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Oncology Institute.
Diversification Opportunities for Vivos Therapeutics and Oncology Institute
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vivos and Oncology is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and The Oncology Institute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on The Oncology Institute and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Oncology Institute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of The Oncology Institute has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Oncology Institute go up and down completely randomly.
Pair Corralation between Vivos Therapeutics and Oncology Institute
Given the investment horizon of 90 days Vivos Therapeutics is expected to generate 3.34 times less return on investment than Oncology Institute. But when comparing it to its historical volatility, Vivos Therapeutics is 2.04 times less risky than Oncology Institute. It trades about 0.09 of its potential returns per unit of risk. The Oncology Institute is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 1.15 in The Oncology Institute on September 3, 2024 and sell it today you would earn a total of 0.74 from holding The Oncology Institute or generate 64.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 87.5% |
| Values | Daily Returns |
Vivos Therapeutics vs. The Oncology Institute
Performance |
| Timeline |
| Vivos Therapeutics |
| The Oncology Institute |
Vivos Therapeutics and Oncology Institute Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vivos Therapeutics and Oncology Institute
The main advantage of trading using opposite Vivos Therapeutics and Oncology Institute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Oncology Institute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncology Institute will offset losses from the drop in Oncology Institute's long position.| Vivos Therapeutics vs. Tandem Diabetes Care | Vivos Therapeutics vs. Inspire Medical Systems | Vivos Therapeutics vs. Penumbra | Vivos Therapeutics vs. Insulet |
| Oncology Institute vs. Select Medical Holdings | Oncology Institute vs. Encompass Health Corp | Oncology Institute vs. Pennant Group | Oncology Institute vs. InnovAge Holding Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |